De novo and inherited deletions of the 5q13 region in spinal muscular atrophies.

PubWeight™: 2.87‹?› | Rank: Top 1%

🔗 View Article (PMID 7910982)

Published in Science on June 03, 1994

Authors

J Melki1, S Lefebvre, L Burglen, P Burlet, O Clermont, P Millasseau, S Reboullet, B Bénichou, M Zeviani, D Le Paslier

Author Affiliations

1: Unité de Recherches sur les Handicaps Génétiques de l'Enfant, INSERM U-393, Hôpital des Enfants-Malades, Paris, France.

Associated clinical trials:

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy | NCT00227266

Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy | NCT00374075

CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I | NCT00661453

Articles citing this

A novel nuclear structure containing the survival of motor neurons protein. EMBO J (1996) 4.72

Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29

Duplication hotspots, rare genomic disorders, and common disease. Curr Opin Genet Dev (2009) 2.96

Validating therapeutic targets through human genetics. Nat Rev Drug Discov (2013) 2.94

Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J Cell Biol (1999) 2.93

Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli. J Cell Biol (2000) 2.78

Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol (2005) 2.44

When is a deletion not a deletion? When it is converted. Am J Hum Genet (1997) 2.38

Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet (1995) 2.33

Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet (1999) 2.21

De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet (1997) 2.05

Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet (1997) 1.74

Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet (1998) 1.56

Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet (2012) 1.52

Chromosomal duplications in bacteria, fruit flies, and humans. Am J Hum Genet (1996) 1.45

Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol (2004) 1.45

The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. Am J Hum Genet (1997) 1.41

Perceptions of equine-assisted activities and therapies by parents and children with spinal muscular atrophy. Pediatr Phys Ther (2014) 1.38

Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci U S A (1995) 1.37

Association between Ag1-CA alleles and severity of autosomal recessive proximal spinal muscular atrophy. Am J Hum Genet (1994) 1.33

Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease. Am J Hum Genet (1996) 1.32

Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol (2011) 1.32

Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology (2012) 1.31

High-resolution genetic and physical map of the Lgn1 interval in C57BL/6J implicates Naip2 or Naip5 in Legionella pneumophila pathogenesis. Genome Res (2000) 1.26

Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet (2008) 1.17

Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes. Results Probl Cell Differ (2009) 1.17

Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. Am J Hum Genet (1996) 1.10

Spinal muscular atrophy genetic testing experience at an academic medical center. J Mol Diagn (2002) 1.03

Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease. J Med Genet (1996) 1.02

Complex repetitive arrangements of gene sequence in the candidate region of the spinal muscular atrophy gene in 5q13. Am J Hum Genet (1994) 1.01

Gene deletions in spinal muscular atrophy. J Med Genet (1996) 0.99

Survival motor neuron gene deletion in the arthrogryposis multiplex congenita-spinal muscular atrophy association. J Clin Invest (1996) 0.95

Calcium binding is essential for plastin 3 function in Smn-deficient motoneurons. Hum Mol Genet (2013) 0.94

The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am J Hum Genet (1999) 0.94

A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites. Eur J Hum Genet (2011) 0.93

Spinal muscular atrophy disease: a literature review for therapeutic strategies. J Med Life (2010) 0.92

Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB/N mice. Neurobiol Dis (2011) 0.89

Neonatal spinal muscular atrophy with diaphragmatic paralysis is unlinked to 5q11.2-q13. J Med Genet (1995) 0.87

Therapeutic developments in spinal muscular atrophy. Ther Adv Neurol Disord (2010) 0.87

A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins. J Neurol (2007) 0.87

De novo deletions in spinal muscular atrophy: implications for genetic counselling. J Med Genet (1997) 0.85

Linkage disequilibrium and haplotype analysis among Polish families with spinal muscular atrophy. Am J Hum Genet (1995) 0.84

Refinement of the spinal muscular atrophy locus by genetic and physical mapping. Am J Hum Genet (1995) 0.83

Homozygous SMN2 deletion is a protective factor in the Swedish ALS population. Eur J Hum Genet (2012) 0.83

Genomic rearrangements in childhood spinal muscular atrophy: linkage disequilibrium with a null allele. J Med Genet (1995) 0.83

Spinal muscular atrophy. J Inherit Metab Dis (1999) 0.82

Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family. Am J Hum Genet (1998) 0.81

Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project. BMC Med Genet (2015) 0.80

Evidence for compound heterozygosity causing mild and severe forms of autosomal recessive spinal muscular atrophy. J Med Genet (1996) 0.79

Molecular diagnosis of spinal muscular atrophy. Arch Dis Child (1998) 0.78

Self-locomotion and spatial language and spatial cognition: insights from typical and atypical development. Front Psychol (2014) 0.75

Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III. J Physiol (2016) 0.75

Proximal and distal spinal muscular atrophy in one family: molecular genetic studies provide further evidence for the non-allelic origin of both diseases. J Med Genet (1997) 0.75

Enhanced expression of the central survival of motor neuron (SMN) protein during the pathogenesis of osteoarthritis. J Cell Mol Med (2013) 0.75

Molecular genetics of autosomal recessive spinal muscular atrophy. Mol Med (1996) 0.75

Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy. Eur J Hum Genet (2009) 0.75

SMN gene analysis of the spinal form of Charcot-Marie-Tooth disease. J Med Genet (1997) 0.75

Molecular study of spinal muscular atrophy patients with hybrid genes in Bulgaria. J Inherit Metab Dis (1999) 0.75

Deletions in the SMN gene in infantile and adult spinal muscular atrophy patients from the same family. Hum Genet (1996) 0.75

Articles by these authors

A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61

The 1993-94 Généthon human genetic linkage map. Nat Genet (1994) 17.64

Identification and characterization of a spinal muscular atrophy-determining gene. Cell (1995) 17.41

A second-generation linkage map of the human genome. Nature (1992) 16.32

Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet (1997) 6.08

Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37

Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09

Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med (1989) 4.87

Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet (1997) 4.43

Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41

Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet (1998) 3.86

Mitochondrial myopathies. Ann Neurol (1985) 3.81

The CIC library: a large insert YAC library for genome mapping in Arabidopsis thaliana. Plant J (1995) 3.79

Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature (1990) 3.77

The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell (1991) 3.59

Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nat Genet (1996) 3.51

Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet (1997) 3.48

Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet (1990) 3.12

Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci U S A (1990) 3.09

Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet (1998) 3.08

A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science (1989) 3.02

Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science (2000) 2.66

Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology (2001) 2.65

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59

Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta (2004) 2.52

Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet (1993) 2.40

The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood (1995) 2.30

A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet (1995) 2.24

Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20

Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect Immun (2000) 2.19

Identification of the gene encoding the human mitochondrial RNA polymerase (h-mtRPOL) by cyberscreening of the Expressed Sequence Tags database. Hum Mol Genet (1997) 2.15

Structure and organization of the human survival motor neurone (SMN) gene. Genomics (1996) 2.12

PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol (2000) 2.05

Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01

Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis. J Med Genet (2005) 2.00

Evidence that nebulin is a protein-ruler in muscle thin filaments. FEBS Lett (1991) 1.87

Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science (1991) 1.82

Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology (1986) 1.78

Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis (2008) 1.77

The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J Virol (1992) 1.76

A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum Mol Genet (1994) 1.67

Characterization of SURF-1 expression and Surf-1p function in normal and disease conditions. Hum Mol Genet (1999) 1.66

Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol (1999) 1.63

Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet (1993) 1.61

In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy. J Antimicrob Chemother (2001) 1.57

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56

Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55

Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet (1995) 1.54

Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (1994) 1.51

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells. Mitochondrion (2012) 1.49

Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A (1996) 1.47

Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43

Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet (1996) 1.42

The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. Am J Hum Genet (1997) 1.41

Single-stranded-DNA-binding proteins from human mitochondria and Escherichia coli have analogous physicochemical properties. Eur J Biochem (1994) 1.41

Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40

GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology (2006) 1.39

Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1, COX15, and COX11, five genes involved in the formation and function of the mitochondrial respiratory chain. Genomics (1998) 1.38

Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol (1998) 1.37

An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet (1995) 1.36

The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J Biol Chem (2000) 1.35

MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology (1988) 1.34

Subunit Va of human and bovine cytochrome c oxidase is highly conserved. Gene (1988) 1.33

Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother (2001) 1.32

Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet (1997) 1.28

Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol (1989) 1.28

Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28

Linkage analysis in spinal muscular atrophy, by six closely flanking markers on chromosome 5. Am J Hum Genet (1991) 1.26

Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet (2001) 1.25

Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology (1985) 1.25

Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Hum Mol Genet (1995) 1.24

Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. Hum Mol Genet (1996) 1.23

Anaerobic ammonium oxidation by marine and freshwater planctomycete-like bacteria. Appl Microbiol Biotechnol (2003) 1.21

Shy1p occurs in a high molecular weight complex and is required for efficient assembly of cytochrome c oxidase in yeast. FEBS Lett (2001) 1.20

Nuclear DNA origin of cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence based on patient's-derived rho degrees transformants. Hum Mol Genet (1995) 1.20

Expanding the clinical and neuroradiologic phenotype of primary microcephaly due to ASPM mutations. Neurology (2009) 1.19

Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations. Neuromuscul Disord (2001) 1.18

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect (2011) 1.18

Improved control of partial DNA restriction enzyme digest in agarose using limiting concentrations of Mg++. Nucleic Acids Res (1989) 1.18

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 1.18

A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome. Hum Mol Genet (2001) 1.18

Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet (2008) 1.16

Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology (1993) 1.16

Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. Hum Mol Genet (1996) 1.16

Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval. Am J Hum Genet (1994) 1.14

A novel frameshift mutation of the mtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patient affected by Leigh-like syndrome. Hum Mol Genet (2000) 1.13

The human immunoglobulin heavy variable genes. Exp Clin Immunogenet (1999) 1.13

Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ (2011) 1.13

Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet (2006) 1.12

Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet (1994) 1.12